The PIO II Study: A Randomized Controlled Blinded Trial to Evaluate the Safety and Efficacy of In-office Placement of a Steroid-eluting Sinus Implant Post-ethmoidectomy
Phase of Trial: Phase IV
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Mometasone (Primary)
- Indications Rhinosinusitis
- Focus Therapeutic Use
- Acronyms PIO II
- 22 Nov 2016 Status changed from active, no longer recruiting to completed.
- 06 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 13 Feb 2016 New trial record